DOCSLIB.ORG

Numerical Chromosome 1, 7, 9, and 11 Aberrations in Bladder Cancer Detected by in Situ Hybridization1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Numerical Chromosome 1, 7, 9, and 11 Aberrations in Bladder Cancer Detected by in Situ Hybridization1 [CANCER RESEARCH 51, 644-651, January 15. 1991] Numerical Chromosome 1, 7, 9, and 11 Aberrations in Bladder Cancer Detected by in Situ Hybridization1 Anton H. N. Hopman,2 Olof Moesker, A. Wim G. B. Smeets, Ruud P. E. Pauwels, G. Peter Vooijs, and Frans C. S. Ramaekers Department of Pathology, L'niversity //ospitai Nijmegen, fieert Grooteplein Zulu 24, 6525 (iA, .\ijmegen ¡A.H. N. H., O. .\t., C. P. ('./.' Stickling Ziekenkuisapotkeek en Klinisch Laboratorium l'enray [A. H'. G. B. S.J; Department of Urology, Hospital I enlo-1 'enray [R. P. K. P.], and Department of Molecular Cell Biology, L'nirersity ofLimhurg, Maastricht ¡A.H. N. H., F. C. S. R.], The Netherlands. ABSTRACT studies we demonstrated that this approach enables a routine screening of large tumor cell populations in, for example, Forty transitional cell carcinomas of the human urinary bladder (TCCs) TCCs4 (5, 10). Furthermore, ISH enables the detection of minor were examined for numerical aberrations of chromosomes 1, 7, 9, and 11 by in situ hybridization using chromosome-specific probes. Our inter- cell populations or imbalance in chromosome copy number phase cytogenetic study of 24 low-grade, noninvasive TCCs, which were within one tumor. near-diploid by flow cytometry, showed a numerical aberration for at By means of conventional karyotyping nonrandom chromo least I of these chromosomes in 14 of these cases. Most strikingly, a some aberrations involving chromosomes 1, 7, 9, and 11 have monosomy for chromosome 9 was found in 9 of 24 low-grade TCCs. A been detected in bladder cancer. Table 1 summarizes the chro trisomy for chromosomes 1, 7, and 11 was detected in 5, 2, and 1 case(s), respectively. In 1 case a monosomy for chromosome 1 was detected by mosomal aberrations in TCCs with a modal chromosome num in situ hybridization. Monosomy for chromosome 9 was the only detected ber of 2 n described in the literature thus far (17-25). Of 52 numerical change in 5 low-grade TCC cases. Examination of 16 invasive described cases, 32 tumors showed affected chromosomes 1, 7, TCCs showed extra copies for chromosomes 1 and 7 in 7 flow cytometr- 9, or 11. Monosomy for chromosome 9 was observed in 15 ically diploid cases with numerical chromosome aberrations; also, loss of cases, in which this aberration was the only karyotypic change chromosome 9 was detected. In 5 invasive and 2 noninvasive aneuploid/ observed in about 40% of these tumors. In the noninvasive tetraploid TCCs a profound imbalance between the different chromo cancers, monosomy 9 was detected in 6 of 12 cases. With somes was found. In 5 of these cases an evident underrepresentation of chromosome 9 in comparison to chromosomes 1, 7, and 11 was detected. progression of the disease numerical and structural abnormali This underrepresentation of chromosome 9 in diploid, as well as aneu ties of chromosomes 1, 7, and 11 have been suggested to occur ploid, TCCs, and in some cases the constant ratio between this chromo in higher numbers of tumors. Furthermore, allelic loss on some and the other chromosomes, may be explained by a process of chromosomes 9, 11, and 17 has been found recently in high- tetraploidization. Therefore, loss of chromosome 9 may be one of the stage, high-grade TCCs by screening of loci on these chromo primary genetic events in TCC oncogenesis, with secondary events, such somes by restriction fragment length polymorphism analysis as tetraploidization, correlated to tumor progression. Our results show (26,27). that in situ hybridization can be routinely used to study important For the underlying study we used probes that recognize highly- cytogenetic changes which occur during the development of a malignant disease. repetitive sequences in the centromeric regions of chromosomes 1,7,9, and 11 (28-31 ). The number of ISH signals, which was found to be constant during the entire cell cycle, in the inter- INTRODUCTION phase nucleus and in the condensed chromosomes indicates the The cellular DNA content of certain malignancies is regarded chromosome copy number independent from the cell cycle stage as a prognostic parameter. Therefore, the FCM analysis became (5, 6, 10). Although the DNA probes used in these experiments a rapid and objective screening method for the DNA content detect highly repetitive genomic sequences and their target of malignant tumor cells (1-3). However, no small variations covers only a limited part of the chromosome, their applicability in DNA content can be detected. Karyotyping of solid tumors is best demonstrated by comparing cytogenetic and flow cyto- is a more precise approach and detects numerical and/or struc metric data. tural chromosomal defects (4). However, when tumor cells are Screening of 40 noninvasive and invasive TCCs by in situ cultured to obtain more and better metaphases rather than hybridization with these chromosome probes is of particular using direct analysis, a potential danger of loss of genetic interest in view of the following questions: (a) Can ISH screen material and selection of certain fast growing subpopulations is ing of TCCs be applied to the detection of numerical chromo present. some aberrations described by karyotyping in literature? (b) In situ hybridization using specific probes and nonisotopic Can the recent findings of loss of chromosome 9q (26) in high- detection procedures allows the detection of numerical (5-12) stage, high-grade tumors be confirmed by the use of a chro and structural chromosome aberrations in nonmitotic cells (13- 16). This method of interphase cytogenetics has already been mosome 9 repetitive centromeric probe? and (c) Is tetraploidi applied to several types of malignancies (7-11). In earlier zation a crucial step in genetic progression of solid tumors, in which random as well as nonrandom loss of chromosomes Received 7/18/90; accepted 10/26/90. could lead to selection and growth of cells to aneuploid or The costs of publication of this article were defrayed in part by the payment heteroploid cells (32-36)? of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1This work was supported by the Netherlands Cancer Foundation. NUKC 'The abbreviations used are: TCC. transitional cell carcinoma of the human 88-6. urinary bladder; ISH, in situ hybridization; FCM, flow cytometry; DI. DNA 2To whom requests for reprints should be addressed, at Department of index; PBS, phosphate-buffered saline; SSC, standard sodium citrate; FITC, Molecular Cell Biology. University of Limburg. Faculty of Medicine, P.O Box fluorescein isothiocyanate; RFLP, restriction fragment length polymorphism; 616. 6200 M D Maastricht. The Netherlands. TRITC. rhodanin isothiocyanate. 644 Downloaded from cancerres.aacrjournals.org on October 2, 2021. © 1991 American Association for Cancer Research. INTERPHASE CVTOGENETICS IN BLADDER CANCER Table 1 Summary of results described in the literature with respect to chromosome I, 7, 9, and 11 aberrations in handed near-diploid transitional cell carcinomas of the urinary bladder involving chromosome chromosomes I, Author(s)Gibas« tumors"65416587luCase25723456121135679234568367132\23GradeGno. orrange45474542-4544-4546464645424746464745-48464646-504746454746444245/4639-424941-454745Aberrations1-9. 7, 9. and 1 ft al.(18)Atkin 2Gjc;2G,G,G,G2G,G,-G2G3G2NGNGNGNGG2G2G2G,G2G2Ci;G3<;2G,G,Ci,G2G2G2G,StageT.T,T.T2T,T,T,T2T,T3T.NGNGNGNGT./T,T./T.T./T,Tu/T,T.T.T.T.T,T,T,T.T.T.T.T,Modal-11-7. -9-9lp-llp-llq+. (19)Gibasand Baker -9i(lq), llp-.-9t(X;l), llqder(l)+7+7-9, (20)Sandbergétal. (21)Bergerétal. (22)Sandberget al. ¡<9q)-9+7Examples, (23)Baba -9Deletion +7. et al.(24)Smeets llpDuplication7q, 9q, IqDeletion 11p.duplication Iq+79q--99q++ (25)Vanniet al. IP-+ lp-, -9.llp+-7, -9,(t7:9)-9/del(9)(ql2)-9-I,del(l)(q21), et al. (26)Ail -9-9+79p-, llp- ' Number of patients examined with a near-diploid chromosome number. *G. grade: T, tumor: NG. not given. MATERIALS AND METHODS 10% dextran sulfate-1 Mg/M'salmon sperm DNA as carrier DNA. Under these stringent conditions, hybridization to minor binding sites was avoided. Hybridization mixture, 5 /il, was added to the slides under a Samples. Forthy fresh TCC specimens (clinical and ISH data sum coverslip (18 x 18 mm) and denaturated on the bottom of a metal box marized in Tables 2 and 4) were obtained immediately after transure- in a water bath at 70°Cfor 3 min. Hybridization was performed thral resection. PCM and direct karyotyping was performed as de overnight at 37°C.Posthybridization washings were done twice in 60% scribed previously (24, 37). The DNA content is expressed as the DI. formamide-2x SSC at 42°Cfor 5 min and twice in PBS containing The TCCs were qualified FCM (near)-diploid (Dl = 0.9-1.1), FCM 0.05% Tween-20 at room temperature. Single-target ISH reactions aneuploid (DI = 1.2-1.7, >2.2), and FCM tetraploid (DI = 1.8-2.2). were performed using biotinylated probes, immunocytochemically proc Tumor Cell Processing for in Situ Hybridization. Preparation of slides essed using FITC-conjugated avidin, and. if necessary, immunologically from the cell suspensions, as well as steps necessary for removal of amplified using biotin-labeled goat anti-avidin followed by a second cytoplasm to improve DNA probe and antibody penetration, was per layer of FITC-conjugated avidin. Double-target ISH using biotin-la formed as previously described (10, 38). Briefly, 5 ¿/Iofa TCC cell beled and digoxigenin-labeled probes were hybridized simultaneously suspension was dropped onto poly-/-lysine-coated glass slides, air dried, and immunochemically processed using monoclonal anti-digoxin and heated at 80°Cfor 60 min. Thereafter digestion with pepsin from (Sigma) in PBS-4% normal rabbit serum, followed by incubation of porcine stomach mucosa (2500-3500 units/mg protein; Sigma Chem FITC-conjugated avidin and TRITC-conjugated rabbit anti-mouse an ical Co., St.
Load more

Recommended publications
  • Epigenetic Control of Mammalian Centromere Protein Binding: Does DNA Methylation Have a Role?
    Journal of Cell Science 109, 2199-2206 (1996) 2199 Printed in Great Britain © The Company of Biologists Limited 1996 JCS3386 Epigenetic control of mammalian centromere protein binding: does DNA methylation have a role? Arthur R. Mitchell*, Peter Jeppesen, Linda Nicol†, Harris Morrison and David Kipling MRC Human Genetics Unit, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK *Author for correspondence (internet [email protected]) †Present address: MRC Reproductive Biology Unit, Edinburgh, UK SUMMARY Chromosome 1 of the inbred mouse strain DBA/2 has a block of minor satellite DNA sequences on chromosome 1. polymorphism associated with the minor satellite DNA at The binding of the CENP-E protein does not appear to be its centromere. The more terminal block of satellite DNA affected by demethylation of the minor satellite sequences. sequences on this chromosome acts as the centromere as We present a model to explain these observations. This shown by the binding of CREST ACA serum, anti-CENP- model may also indicate the mechanism by which the B and anti-CENP-E polyclonal sera. Demethylation of the CENP-B protein recognises specific sites within the arrays minor satellite DNA sequences accomplished by growing of minor satellite DNA on mouse chromosomes. cells in the presence of the drug 5-aza-2′-deoxycytidine results in a redistribution of the CENP-B protein. This protein now binds to an enlarged area on the more terminal Key words: Centromere satellite DNA, Demethylation, Centromere block and in addition it now binds to the more internal antibody INTRODUCTION A common feature of many mammalian pericentromeric domains is that they contain families of repetitive DNA The centromere of mammalian chromosomes is recognised at sequences (Singer, 1982).
    [Show full text]
  • Microcephaly Genes and Risk of Late-Onset Alzheimer Disease
    ORIGINAL ARTICLE Microcephaly Genes and Risk of Late-onset Alzheimer Disease Deniz Erten-Lyons, MD,*w Beth Wilmot, PhD,zy Pavana Anur, BS,z Shannon McWeeney, PhD,zyJ Shawn K. Westaway, PhD,w Lisa Silbert, MD,w Patricia Kramer, PhD,w and Jeffrey Kaye, MD*w Alzheimer’s Disease Neuroimaging Initiative ratio=3.41; confidence interval, 1.77-6.57). However, this associa- Abstract: Brain development in the early stages of life has been tion was not replicated using another case-control sample research suggested to be one of the factors that may influence an individual’s participants from the Alzheimer Disease Neuroimaging Initiative. risk of Alzheimer disease (AD) later in life. Four microcephaly We conclude that the common variations we measured in the 4 genes, which regulate brain development in utero and have been microcephaly genes do not affect the risk of AD or that their effect suggested to play a role in the evolution of the human brain, were size is small. selected as candidate genes that may modulate the risk of AD. We examined the association between single nucleotide polymorphisms Key Words: Alzheimer disease, microcephaly genes, cognitive tagging common sequence variations in these genes and risk of AD reserve in two case-control samples. We found that the G allele of (Alzheimer Dis Assoc Disord 2011;25:276–282) rs2442607 in microcephalin 1 was associated with an increased risk of AD (under an additive genetic model, P=0.01; odds Received for publication June 2, 2010; accepted December 2, 2010. enetics has been suggested to play a role in variations From the *Portland Veterans Affairs Medical Center; wDepartment of Gin cognitive function in late life.1 One way in which Neurology; zOregon Clinical and Translational Research Center; genes may play a role in cognitive function in late life is yDivision of Bioinformatics and Computational Biology, Depart- through providing an “initial endowment” that is more ment of Medical Informatics and Clinical Epidemiology; and JDivision of Biostatistics, Department of Public Health and resistant to age-related changes.
    [Show full text]
  • Familial Bone Marrow Monosomy 7 Evidence That the Predisposing Locus Is Not on the Long Arm of Chromosome 7 Kevin M
    Familial Bone Marrow Monosomy 7 Evidence That the Predisposing Locus Is Not on the Long Arm of Chromosome 7 Kevin M. Shannon,* All G. Turhan,*$ Sharon S. Y. Chang,"1 Anne M. Bowcock,' Paul C. J. Rogers,** William L. Carroll,# Morton J. Cowan,* Bertil E. Glader,* Connie J. Eaves, *1111 Allen C. Eaves,t1111 and Yuet Wai Kan1ltl Departments of*Pediatrics and "'Medicine and 1lHoward Hughes Medical Institute, University of California, San Francisco, San Francisco, California 94143; Departments of Pathology, **Pediatrics, and 111IMedicine, University ofBritish Columbia, and the §Terry Fox Laboratory, British Columbia Cancer Centre, Vancouver, British Columbia, Canada; Departments of'Genetics and "Pediatrics, Stanford University Medical School, Stanford, California 94303; and t*Department ofPediatrics, Washington University School of Medicine, St. Louis, Missouri 63110 Abstract cinogen exposure (3, 6). The age distribution of these de novo cases shows peaks in the first and fifth decades (6). Overall, Loss of expression of a tumor-suppressing gene is an attractive monosomy 7 or 7q- is identified in - 5% of de novo and in model to explain the cytogenetic and epidemiologic features of 40% of secondary cases of AML (1, 3-5). Although childhood cases of myelodysplasia and acute myelogenous leukemia bone marrow monosomy 7 is an uncommon disorder, it has (AML) associated with bone marrow monosomy 7 or partial been observed in two or more siblings at least seven times deletion of the long arm (7q-). We used probes from within the (7-10, Lange, B. J., personal communication, and our unpub- breakpoint region on 7q- chromosomes (7q22-34) that detect lished data).
    [Show full text]
  • The Cytogenetics of Hematologic Neoplasms 1 5
    The Cytogenetics of Hematologic Neoplasms 1 5 Aurelia Meloni-Ehrig that errors during cell division were the basis for neoplastic Introduction growth was most likely the determining factor that inspired early researchers to take a better look at the genetics of the The knowledge that cancer is a malignant form of uncon- cell itself. Thus, the need to have cell preparations good trolled growth has existed for over a century. Several biologi- enough to be able to understand the mechanism of cell cal, chemical, and physical agents have been implicated in division became of critical importance. cancer causation. However, the mechanisms responsible for About 50 years after Boveri’s chromosome theory, the this uninhibited proliferation, following the initial insult(s), fi rst manuscripts on the chromosome makeup in normal are still object of intense investigation. human cells and in genetic disorders started to appear, fol- The fi rst documented studies of cancer were performed lowed by those describing chromosome changes in neoplas- over a century ago on domestic animals. At that time, the tic cells. A milestone of this investigation occurred in 1960 lack of both theoretical and technological knowledge with the publication of the fi rst article by Nowell and impaired the formulations of conclusions about cancer, other Hungerford on the association of chronic myelogenous leu- than the visible presence of new growth, thus the term neo- kemia with a small size chromosome, known today as the plasm (from the Greek neo = new and plasma = growth). In Philadelphia (Ph) chromosome, to honor the city where it the early 1900s, the fundamental role of chromosomes in was discovered (see also Chap.
    [Show full text]
  • WNT16 Is a New Marker of Senescence
    Table S1. A. Complete list of 177 genes overexpressed in replicative senescence Value Gene Description UniGene RefSeq 2.440 WNT16 wingless-type MMTV integration site family, member 16 (WNT16), transcript variant 2, mRNA. Hs.272375 NM_016087 2.355 MMP10 matrix metallopeptidase 10 (stromelysin 2) (MMP10), mRNA. Hs.2258 NM_002425 2.344 MMP3 matrix metallopeptidase 3 (stromelysin 1, progelatinase) (MMP3), mRNA. Hs.375129 NM_002422 2.300 HIST1H2AC Histone cluster 1, H2ac Hs.484950 2.134 CLDN1 claudin 1 (CLDN1), mRNA. Hs.439060 NM_021101 2.119 TSPAN13 tetraspanin 13 (TSPAN13), mRNA. Hs.364544 NM_014399 2.112 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 2.070 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 2.026 DCBLD2 discoidin, CUB and LCCL domain containing 2 (DCBLD2), mRNA. Hs.203691 NM_080927 2.007 SERPINB2 serpin peptidase inhibitor, clade B (ovalbumin), member 2 (SERPINB2), mRNA. Hs.594481 NM_002575 2.004 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 1.989 OBFC2A Oligonucleotide/oligosaccharide-binding fold containing 2A Hs.591610 1.962 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 1.947 PLCB4 phospholipase C, beta 4 (PLCB4), transcript variant 2, mRNA. Hs.472101 NM_182797 1.934 PLCB4 phospholipase C, beta 4 (PLCB4), transcript variant 1, mRNA. Hs.472101 NM_000933 1.933 KRTAP1-5 keratin associated protein 1-5 (KRTAP1-5), mRNA. Hs.534499 NM_031957 1.894 HIST2H2BE histone cluster 2, H2be (HIST2H2BE), mRNA. Hs.2178 NM_003528 1.884 CYTL1 cytokine-like 1 (CYTL1), mRNA. Hs.13872 NM_018659 tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain (TNFRSF10D), 1.848 TNFRSF10D Hs.213467 NM_003840 mRNA.
    [Show full text]
  • Gene Mapping of Familial Autosomal Dominant Dilated Cardiomyopathy to Chromosome 10Q21-23
    Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. K R Bowles, … , R Pignatelli, J A Towbin J Clin Invest. 1996;98(6):1355-1360. https://doi.org/10.1172/JCI118922. Research Article Dilated cardiomyopathy (DCM) is the most common form of primary myocardial disorder, accounting for 60% of all cardiomyopathies. In 20-30% of cases, familial inheritance can be demonstrated; an autosomal dominant transmission is the usual type of inheritance pattern identified. Previously, genetic heterogeneity was demonstrated in familial autosomal dominant dilated cardiomyopathy (FDCM). Gene localization to chromosome 1 (1p1-1q1 and 1q32), chromosome 3 (3p25-3p22), and chromosome 9 (9q13-9q22) has recently been identified. We report one family with 26 members (12 affected) with familial autosomal dominant dilated cardiomyopathy in which linkage to chromosome 10 at the 10q21-q23 locus is identified. Using short tandem repeat polymorphism (STR) markers with heterozygosity > 70%, 169 markers (50% of the genome) were used before linkage was found to markers D10S605 and D10S201 with a pairwise LOD score = 3.91, theta = 0, penetrance = 100% for both markers. Linkage to 1p1-1q1, 1q32, 3p25-3p22, and 9q13-9q22 was excluded. We conclude that a new locus for pure autosomal dominant FDCM exists, and that this gene is localized to a 9 cM region of 10q21-10q23. The search for the disease causing gene and the responsible mutation(s) is ongoing. Find the latest version: https://jci.me/118922/pdf Gene Mapping of Familial Autosomal Dominant Dilated Cardiomyopathy to Chromosome 10q21-23 Karla R. Bowles,* Robert Gajarski,‡ Patrick Porter,‡ Veronica Goytia,‡ Linda Bachinski,ʈ Robert Roberts,ʈ Ricardo Pignatelli,‡ and Jeffrey A.
    [Show full text]
  • Centromeric Copy Number of Chromosome 7 Is Strongly Correlated with Tumor Grade and Labeling Index in Human Bladder Cancer1
    (CANCER RESEARCH 51, 3807-3813. July 15, 1991] Centromeric Copy Number of Chromosome 7 Is Strongly Correlated with Tumor Grade and Labeling Index in Human Bladder Cancer1 Frederic M. Waldman,2 Peter R. Carroll, Russell Kerschmann, Michael B. Cohen,3 Frederick G. Field, and Brian H. Mayall Departments of Laboratory Medicine [F. M. W., F. G. F., B. H. M.], Pathology [R. K., M. B. C.¡,and Urology ¡P.R. C.J, University of California San Francisco, San Francisco, California 94143-0808 BrdUrd4 into tumor DNA5 or by immunohistochemical staining ABSTRACT of cell cycle-specific antigens such as Ki67 (21) or PCNA (22) The relationship between interphase cytogenetics and tumor grade, expressed only in proliferating cells. The present study was stage, and proliferative activity was investigated in 27 transitional cell undertaken in order to study the relationships in bladder cancer carcinomas of the urinary bladder. Using fluorescence in situ hybridiza between genotypic and phenotypic abnormalities. Tumor grade, tion with chromosome-specific DNA probes, the copy number of pericen- tumor stage, and tumor labeling index, as measured by BrdUrd tromeric sequences on chromosomes 7, 9, and 11 was detected within incorporation or PCNA labeling, were used to characterize interphase nuclei in touch preparations from tumor biopsies. Monosomy tumor phenotype, while tumor genotype was defined by cyto- of chromosome 9 was detected in 9 of 22 cases (41%), while tetrasomy genetic abnormalities, as detected by FISH with DNA probes for chromosomes 7 and 11 was detected in 10 of 26 (38%) and 6 of 23 specific for chromosomes 7, 9, and 11.
    [Show full text]
  • Centromere Repositioning Causes Inversion of Meiosis and Generates a Reproductive Barrier
    Centromere repositioning causes inversion of meiosis and generates a reproductive barrier Min Lua and Xiangwei Hea,1 aMinistry of Education Key Laboratory of Biosystems Homeostasis & Protection and Innovation Center for Cell Signaling Network, Life Sciences Institute, Zhejiang University, 310058 Hangzhou, Zhejiang, China Edited by J. Richard McIntosh, University of Colorado, Boulder, CO, and approved September 20, 2019 (received for review July 10, 2019) The chromosomal position of each centromere is determined postulated that a neocentromere may seed the formation of an epigenetically and is highly stable, whereas incremental cases ENC at a site devoid of satellite DNA, which is then matured have supported the occurrence of centromere repositioning on an through acquisition of repetitive DNA. ENCs and neocentromeres evolutionary time scale (evolutionary new centromeres, ENCs), are considered as two sides of the same coin, manifestations of the which is thought to be important in speciation. The mechanisms same biological phenomenon at drastically different time scales underlying the high stability of centromeres and its functional and population sizes (7). Hence, understanding centromere repo- significance largely remain an enigma. Here, in the fission yeast sitioning may provide mechanistic insights into ENC emergence Schizosaccharomyces pombe, we identify a feedback mechanism: and progression. The kinetochore, whose assembly is guided by the centromere, in CENP-A–containing chromatin directly recruits specific com- turn, enforces centromere stability. Upon going through meiosis, ponents of the kinetochore, called the constitutive centromere- specific inner kinetochore mutations induce centromere reposi- associated network. The kinetochore is a proteinaceous ma- tioning—inactivation of the original centromere and formation chinery comprised of inner and outer parts, each compassing of a new centromere elsewhere—in 1 of the 3 chromosomes at several subcomplexes.
    [Show full text]
  • Cytogenetics and Molecular Genetics of Childhood Brain Tumors 1
    Neuro-Oncology Cytogenetics and molecular genetics of childhood brain tumors 1 Jaclyn A. Biegel 2 Division of Human Genetics and Molecular Biology, The Children’s Hospital of Philadelphia and the Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 Considerable progress has been made toward improving Introduction survival for children with brain tumors, and yet there is still relatively little known regarding the molecular genetic Combined cytogenetic and molecular genetic approaches, events that contribute to tumor initiation or progression. including preparation of karyotypes, FISH, 3 CGH, and Nonrandom patterns of chromosomal deletions in several loss of heterozygosity studies have led to the identica- types of childhood brain tumors suggest that the loss or tion of regions of the genome that contain a variety of inactivation of tumor suppressor genes are critical events novel tumor suppressor genes and oncogenes. Linkage in tumorigenesis. Deletions of chromosomal regions 10q, analysis in families, which segregate the disease pheno- 11 and 17p, for example, are frequent events in medul- type, and studies of patients with constitutional chromo- loblastoma, whereas loss of a region within 22q11.2, somal abnormalities have resulted in the identication of which contains the INI1 gene, is involved in the develop- many of the disease genes for which affected individuals ment of atypical teratoid and rhabdoid tumors. A review have an inherited predisposition to brain tumors (Table of the cytogenetic and molecular genetic changes identi- 1). The frequency of mutations of these genes in sporadic ed to date in childhood brain tumors will be presented. tumors, however, is still relatively low.
    [Show full text]
  • Defining the Genetic Basis of Three Hereditary Neurological Conditions in Families from the Indian Subcontinent
    RETA LILA WESTON INSTITUTE OF NEUROLOGICAL STUDIES INSTITUTE OF NEUROLOGY UNIVERSITY COLLEGE LONDON DEFINING THE GENETIC BASIS OF THREE HEREDITARY NEUROLOGICAL CONDITIONS IN FAMILIES FROM THE INDIAN SUBCONTINENT Dr Vafa Alakbarzade PhD Thesis 2016 1 DEFINING THE GENETIC BASIS OF THREE HEREDITARY NEUROLOGICAL CONDITIONS IN FAMILIES FROM THE INDIAN SUBCONTINENT Submitted by Dr Vafa Alakbarzade, MBBS, MRCP (UK), MSc University College London Student Number: 1028294 to University College London as a thesis for the degree of Doctor of Philosophy, January 2016 This thesis is available for Library use on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement I confirm that the work presented in this thesis is my own and information derived from other sources has been indicated in the thesis (Signature) …………………………………………………… 2 ACKNOWLEDGEMENTS Foremost I would like to thank the families who took part in these studies. I am sincerely grateful to Professor Tom Warner and Professor Andrew Crosby, without whom I would never have had all the wonderful experiences this PhD brought me. They have always supported and encouraged me in whatever scientific endeavours I have followed. Dr. Barry Chioza and Dr. Sreekantan-Nair Ajith provided invaluable support and advice throughout my PhD; I am hugely appreciative of their guidance and encouragement. None of the work in this thesis would have been possible without guidance of Dr. Barry Chioza. I would specifically like to appreciate contribution of the team of Prof. David Silver and Dr. Kulkarni Abhijit who provided functional follow up of our genetic findings and Dr.
    [Show full text]
  • Translocation of Chromosome 10 in an O-2A-Like Cell Line
    British Journal of Cancer (1999) 79(5/6), 724–731 © 1999 Cancer Research Campaign Article no. bjoc.1998.0116 Genetic aberrations in glioblastoma multiforme: translocation of chromosome 10 in an O-2A-like cell line X Mao1, *, TA Jones1, I Tomlinson2, †, AJ Rowan2, †, LI Fedorova3, AV Zelenin3, J-I Mao4, NJ Gutowski5, ‡, M Noble5, § and D Sheer1 1Human Cytogenetics Laboratory and 2Cancer Genetics Laboratory, Imperial Cancer Research Fund, 44 Lincoln’s Inn Fields, London WC2A 3PX, UK; 3Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia, 4Genomics and Technology Development, Genome Therapeutics Corp., 100 Beaver Street, Waltham, MA 02154, USA; 5Ludwig Institute for Cancer Research, 91 Riding House Street, London W1P 8BT, UK Summary We have examined the genetic aberrations in two near-diploid glioblastoma multiforme cell lines that appear to have arisen from different glial lineages. One cell line, Hu-O-2A/Gb1, expresses antigens and metabolic profiles characteristic of the oligodendrocyte-type-2 astrocyte (0-2A) lineage of the rat central nervous system. This line generates, in vitro, cells with characteristics of 0-2A progenitor cells, oligodendrocytes and astrocytes. The second cell line, IN1434, is derived from an astrocyte or a precursor cell restricted to astrocytic differentiation. In Hu-O-2A/Gb1 the sole homologue of chromosome 10 is disrupted at band 10p11–12.1 by translocation with chromosomes X and 15. The translocation breakpoint is localized between genetic markers D10S2103 and [D10S637, D10S1962, D10S355]. Other aberrations include a 5;14 translocation, deletion of the long and short arms of chromosome 16 and loss of one copy of the CDKN2 gene.
    [Show full text]
  • Identification of a Recurring Translocation Site Involving Chromosome 6 in Human Malignant Melanoma1
    (CANCER RESEARCH 49, 420-423, January 15, 1989] Identification of a Recurring Translocation Site Involving Chromosome 6 in Human Malignant Melanoma1 Jeffrey M. Trent, Floyd H. Thompson, and Frank L. Meyskens, Jr. Departments of Radiation Oncology [J. M. T.] and Medicine [J. M. T., F. H. T., F. L. M.¡,Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724 ABSTRACT week of culture initiation. In cases CC-9 and T84-097, cells were grown in agar culture (14), while cases T87-093 and T87-096 were grown in The recognition of recurring sites of chromosome change in human short-term liquid culture (15). Methods for chromosome banding (G- cancers has pinpointed the location in the genome of several important and C-) have been described in detail elsewhere ( 15). No karyotypically growth-regulatory sequences (e.g., cellular oncogenes). This report details normal cells were observed in any tumor culture. C-banding (to recog the finding of a recurring translocation site involving the long arm of nize constitutive heterochromatin) was performed on all cases with chromosome 6 (6q) in malignant melanoma. We have observed a trans- t(l;6) in order to assist the breakpoint location relative to lqll-12. location (I) between chromosomes I and 6 in five different cases of Examination of a minimum of 15 cells and four banded karyotypes was malignant metastatic melanoma. All five melanomas evidencing t(l;6) performed on all cases. The description of chromosome alterations involved band regions 6ql 1-13, while two different regions of chromosome conforms to International System for Human Cytogenetic Nomencla 1 (p22, ql2-q21) were shown to be translocated to 6q.
    [Show full text]